Vol. 10 No. 2 (2018): Archives of Public Health
Public Health

Prevalence of the metabolic syndrome in the Pech district

pdf (Македонски)
  • Ardita Kerveshi-Sulejmani,
  • Aferdita Selmanaj,
  • Igor Isjanovski,
  • Rozalinda Isjanovska
Ardita Kerveshi-Sulejmani
Institute of Public health, Pristina, Kosovo
Aferdita Selmanaj
General Hospital Pekj, Kosovo
Igor Isjanovski
University Clinic for eye diseases; Medical Faculty, University Ss Ciril and Methodius, Skopje, Republic of Macedonia
Rozalinda Isjanovska
Medical Faculty Skopje, University Ss Ciril and Methodius, Skopje, Republic of Macedonia
DOI: https://doi.org/10.3889/aph.2018.2242

Published 2018-11-12

Keywords

  • мetabolic syndrome,
  • public health,
  • prevalence,
  • obesitas

How to Cite

1.
Kerveshi-Sulejmani A, Selmanaj A, Isjanovski I, Isjanovska R. Prevalence of the metabolic syndrome in the Pech district. Arch Pub Health [Internet]. 2018 Nov. 12 [cited 2024 Dec. 18];10(2):40-7. Available from: https://id-press.eu/aph/article/view/2242
Copyright Notice

Abstract

The metabolic syndrome (MS) is the main clinical and public health challenge in the world, in the wake of urbanization, excess energy intake, increased obesity, sedentary lifestyle and habits. MS leads to a 5-fold increase the risk of diabetes mellitus type 2 (T2DM) and 2 times the risk of cardiovascular disease (CVD) over the next 5 to 10 years. The aim of the research is to determine the prevalence of metabolic syndrome syndrome in the Pech District according to NCEP ATD III / 2001. Material and methods: Cross sectional study was carried out at the General Hospital in Pec, which represents a regional hospital for the Pec District. A total of 1667 patients from the Pech district were interviewed for a period of one year. Results: In the group, MS was present in 506 patients. In the majority of cases, we found the systolic blood pressure condition ≥ 130 mmHg -99.4%, followed by diastolic blood pressure ≥ 85 mmH-96.4%, elevated triglycerides ≥ 1.7 mmol / l- 94.7%, waist circumference> 88 cm in women-94.0% , increased glycemia ≥ 6.1mmol / L in 80.0%, waist circumference > 102cm in men-65.5%, HDL values ​​<1.03mmol / L in men - 56.9%  and HDL values ​​<1.03mmol / L in females 51.5%. The mean value of systolic blood pressure in patients with MS is 151.1 ± 9.3 mmHg. The average value of diastolic blood pressure in patients with MS is 91.0 ± 4.7 mmHg. The average waist circumference of patients with MC was 103.6 ± 9.2 cm. The mean HDL of patients with MS is 1.1 ± 0.2 mmol / L. The average glycemic value in patients with MS is 6.5 ± 0.6 mmol / Average triglyceride value in patients with MS and is 2.5 ± 0.8 mmol / L. The most common in patients with MS is obesity / obesity - 70.8%, overweight is 27.8%, and 1.4% normal weight is registered. Conclusions: The prevalence of MS in the Pech district is 30.4% and was approximately as in Croatia 34% and Tetovo region with 28.25%, but it was dependent on the population and definitions used. The metabolic syndrome is one of the major public health problems, and a socioeconomic problem around the world and in  Kosovo, too.

pdf (Македонски)

Downloads

Download data is not yet available.

References

  1. Borch-Johnsen K. The metabolic syndrome in a global perspective. Dan Medical Bulletin 2007; 54(2):157-159.
  2. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the study of obesity. Circulation 2009;120(16): 1640–1645.
  3. Leslie B. Metabolic syndrome: Historical perspectives. The American Journal of the Medical Sciences 2005; 330(6): 264-268.
  4. Lam DW, LeRoith D. Metabolic Syndrome. South Dartmouth (MA): MDText.com, Inc.; 2000-.2017 . Available at https://www.ncbi.nlm.nih.gov/books/NBK278936/
  5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
  6. Grundy S, Cleeman J, Daniels S, Donato K, Eckel B, Franklin B, Gordon D, Krauss R, Savage R, Smith S, Spertus J and Costa F. Diagnosis and management of the metabolic syndrome: An American Heart association/National Heart, Lung and Blood Institute Scientific Statement: Executive Summary. Circulation 2005; 112: 285-290.
  7. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Applied Physiology Nutrition and Metabolism 2007; 32(1): 23–32.
  8. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. The American Journal of the Medical Sciences 2007; 333 (6): 362–371.
  9. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745–2749
  10. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28(4):629-36.
  11. Kohro T, Furui Y, Mitsutake N, et al. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J 2008; 49(2):193-203.
  12. Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. The prevalence of metabolic syndrome in various populations. Am J Med Sci 2007; 333(6):362-71.
  13. Hu G, Lindstrom J, Jousilahti P, et al. The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab 2008; 93(3):832-836.
  14. Erem C, Hacihasanoglu A, Deger O, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine 2008; 33(1):9-20.
  15. Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian-an urban-rural comparison. Metab Syndr Relat Disord 2007; 5(2):142-152 .
  16. Mokan M, Galajda P, Pridavkova D, et al. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Res Clin Pract 2008; 81(2):238-242.
  17. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord 2008; 6(3):177-186.
  18. Rexhepi A. Metabolic syndrome of adults in the population of the region Tetova, The doctoral dissertation, Medical Faculty Tirane 2012.
  19. Athyros VG, Ganotakis ES, Bathianaki M, Monedas I, Goudevenos IA, Papageorgiou AA, Papathanasiou A, Kakafika AI, Mikhailidis DP, Elisaf M. Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J Cardiol 2005;46:380–386.
  20. Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Vaklinova I, Bonov P. High prevalence of metabolic syndrome in populations at high and low cardiovascular risk in Bulgaria Journal of Diabetology 2010; 1:2
  21. Parcalaboiu L. Prevalence of Metabolic Syndrome in an Adult Population from Targu Jiu. Applied Medical Informatics 2010; 27: 23-28.
  22. Moebus S, Hanisch J, Bramlage P, Lösch C, Hauner H, Wasem J, Jöckel K. Regional differences in the prevalence of the metabolic Syndrome in primary care practices in Germany. Dtsch Arztebl Int 2008; 105(12): 207-13;
  23. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. Adults: NHANES III to NHANES 1999–2006. Diabetes Care 2011; 34:216–219.
  24. Lim S, Šin H, Song JH et al. Increasing prevalence of metabolic syndrome in Korea. The Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 2011; 34:1323–1328.
  25. Wagner A, Haas B, Bongard V, Dallongeville J, Cottel D, Ferrières J, Arveiler D. Prevalence and trends of the metabolic syndrome in French adults: the MONALISA Study. Archives of Cardiovascular Diseases Supplements 2010; 2(1): 92–93.
  26. Kaur JA. Comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: 943162.
  27. Pal S, Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity 2010; 18: 1354–1359.
  28. Aguilar M, Bhuket T, Torres Sh,et al. Prevalence of the Metabolic Syndrome in the United States, 2003-2012. JAMA May 19, 2015 Volume 313, Number 19.
  29. Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord 2009; (5):427-34.
  30. Tan AK, Dunn RA, Yen ST. Ethnic disparities in metabolic syndrome in Malaysia: an analysis by risk factors. Metab Syndr Relat Disord 2011; 9(6):441-51.
  31. Beltrán-Sánchez H, Harhay M O, Harhay MM, Elligott Sean. Prevalence and trends of Metabolic Syndrome in the adult US population, 1999–2010. J Am Coll Cardiol 2013; 20;62(8):697-703.

Most read articles by the same author(s)